Publications

Seminars in cancer biology

Immuno-oncology-101: overview of major concepts and translational perspectives.

01-10-2018

European journal of cancer (Oxford, England : 1990)

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04).

01-10-2018

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?

01-07-2018

Oncotarget

Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.

26-12-2017

Annals of oncology : official journal of the European Society for Medical Oncology

LAG-3: another brake to release in breast cancer?

01-12-2017

ESMO open

Targeting immune checkpoints in breast cancer: an update of early results.

28-11-2017

JCO precision oncology

Profound Immunotherapy Response in Mismatch Repair-Deficient Breast Cancer.

01-11-2017

Drugs

Neoadjuvant Therapy for Breast Cancer: Established Concepts and Emerging Strategies.

01-08-2017

Nederlands tijdschrift voor geneeskunde

[No hair loss, but colitis or pneumonitis: unique side effects of immune checkpoint inhibitors for cancer].

22-07-2016

Current opinion in obstetrics & gynecology

Targeting the programmed cell death-1 pathway in breast and ovarian cancer.

01-04-2016

BMC cancer

Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13.

14-08-2015

Molecular oncology

Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.

01-06-2015

Breast (Edinburgh, Scotland)

Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancer.

01-12-2012

The EMBO journal

Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.

14-10-2011

Breast cancer research and treatment

PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer.

01-01-2011

Journal of the National Cancer Institute

Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer.

16-12-2009

The Journal of pathology

Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.

01-07-2009